<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">grekov</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник хирургии имени И.И. Грекова</journal-title><trans-title-group xml:lang="en"><trans-title>Grekov's Bulletin of Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4625</issn><issn pub-type="epub">2686-7370</issn><publisher><publisher-name>Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/0042-4625-2021-180-5-111-117</article-id><article-id custom-type="elpub" pub-id-type="custom">grekov-1878</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Локорегионарные методы лечения больных с холангиокарциномой внепеченочных желчных протоков (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Locoregional methods of treatment of patients with extrahepatic bile duct cholangiocarcinoma (review of literature)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3948-6928</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ивануса</surname><given-names>С. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanusa</surname><given-names>S. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ивануса Сергей Ярославович, доктор медицинских наук, профессор, заслуженный врач РФ, начальник кафедры общей хирургии</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Ivanusa Sergey Ya., Dr. of Sci. (Med.), Professor, Honored Doctor of the Russian Federation, Head of the Department of General Surgery</p><p>194044, Saint Petersburg, Academika Lebedeva str., 6</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4562-113X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алентьев</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Alentev</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алентьев Сергей Александрович, доктор медицинских наук, доцент кафедры общей хирургии</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Alentev Sergey A., Dr. of Sci. (Med.), Associate Professor of the Department of General Surgery</p><p>194044, Saint Petersburg, Academika Lebedeva str., 6</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2201-3959</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евстратьева</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Evstrateva</surname><given-names>D. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евстратьева Дарья Юрьевна, слушатель ординатуры</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Evstrateva Daria Yu., Resident</p><p>194044, Saint Petersburg, Academika Lebedeva str., 6</p></bio><email xlink:type="simple">plotnikowadarja@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5150-1700</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молчанов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Molchanov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Молчанов Александр Алексеевич, зав. отделением клиники общей хирургии</p><p>194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Molchanov Alexander A., Head of the Department of the General Surgery Clinic</p><p>194044, Saint Petersburg, Academika Lebedeva str., 6</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное военное образовательное учреждение высшего образования «Военно-медицинская академия имени С. М. Кирова» Министерства обороны Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Military Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>23</day><month>09</month><year>2021</year></pub-date><volume>180</volume><issue>5</issue><fpage>111</fpage><lpage>117</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ивануса С.Я., Алентьев С.А., Евстратьева Д.Ю., Молчанов А.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Ивануса С.Я., Алентьев С.А., Евстратьева Д.Ю., Молчанов А.А.</copyright-holder><copyright-holder xml:lang="en">Ivanusa S.Y., Alentev S.A., Evstrateva D.Y., Molchanov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vestnik-grekova.ru/jour/article/view/1878">https://www.vestnik-grekova.ru/jour/article/view/1878</self-uri><abstract><p>Представлен литературный обзор исследований, посвященных применению методов локальной деструкции (фотодинамической терапии и радиочастотной абляции) в лечении больных с нерезектабельной внепеченочной холангиокарциномой. В настоящее время опубликовано множество исследований, посвященных оценке фотодинамической терапии в лечении пациентов данной категории. Радиочастотная абляция при опухолях внепеченочных желчных протоков применяется относительно недавно, но, по имеющимся данным, может представлять альтернативу фотодинамической терапии. В статье рассмотрены механизм действия, методика фотодинамической терапии и радиочастотной абляции, приведены результаты наиболее крупных исследований. Сообщается, что по результатам выживаемости фотодинамическая терапия сопоставима с R1/R2-резекцией. Имеются данные об успешном использовании ее в качестве адъювантного и неоадъювантного лечения, о возможности применения фотодинамической терапии в качестве метода локального контроля опухоли у пациентов с нерезектабельной холангиокарциномой, ожидающих трансплантации печени. Применение радиочастотной абляции на первом этапе, перед стентированием желчевыводящих путей, позволяет увеличить диаметр желчных протоков, способствует увеличению времени проходимости стента, а также выживаемости больных. Кроме того, радиочастотная абляция и фотодинамическая терапия могут успешно применяться при окклюзии ранее установленных стентов. Преимуществами фотодинамической терапии является возможность проведения ее у ослабленных больных, с повышенным уровнем билирубина сыворотки крови. К преимуществам радиочастотной абляции можно отнести меньшую стоимость процедуры, а также отсутствие необходимости соблюдения светового режима. Изучаются перспективы использования методов локорегионарной деструкции в составе комбинированных схем лечения (в сочетании с системной или регионарной химиотерапией), что позволяет достичь наилучших результатов.</p></abstract><trans-abstract xml:lang="en"><p>The article presents a literature review of studies on the use of local destruction methods (photodynamic therapy and radiofrequency ablation) in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. Currently, many studies have been published on the assessment of photodynamic therapy in the treatment of patients of this category. Radiofrequency ablation in tumors of extrahepatic bile ducts has been used relatively recently, but, according to available data, it may represent an alternative to photodynamic therapy. The article discusses the mechanism of action, the method of photodynamic therapy and radiofrequency ablation, and presents the results of the largest studies. It is reported that photodynamic therapy is comparable to R1/R2 resection according to the survival results. There is evidence of its successful use as adjuvant and neoadjuvant treatment, the possibility of using photodynamic therapy as a method of local tumor control in patients with unresectable cholangiocarcinoma awaiting liver transplantation. The use of radiofrequency ablation at the first stage before stenting the biliary tract allows to increase the diameter of the bile ducts, increases the stent patency time, as well as the survival orate f patients. In addition, radiofrequency ablation and photodynamic therapy can be successfully applied to occlude previously inserted stents. The advantage of photodynamic therapy is the possibility of using it in weakened patients with hyper bilirubinemia. The advantages of radiofrequency ablation include the lower cost of the procedure, as well as the absence of the need to keep the light regimen. The prospects of using methods of locoregional destruction as part of combined treatment regimens (in combination with systemic or regional chemotherapy) are being studied, which allows achieving the best results.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>холангиоцеллюлярный рак</kwd><kwd>гилюсная холангиокарцинома</kwd><kwd>эндобилиарные вмешательства</kwd><kwd>фотодинамическая терапия</kwd><kwd>радиочастотная абляция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cholangiocellular carcinoma</kwd><kwd>hilus cholangiocarcinoma</kwd><kwd>endobiliary intervention</kwd><kwd>photodynamic therapy</kwd><kwd>radiofrequency ablation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Макаров Е. С. и др. Рак проксимальных желчных протоков. М. : Печатка, 2018. 100 с.</mixed-citation><mixed-citation xml:lang="en">Makarov E. S. i dr. Cancer of the proximal bile ducts. Moscow, Pechatka, 2018:100. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Майстренко Н. А. и др. Холангиоцеллюлярный рак (особенности диагностики и лечения) // Практ. онкология. 2008. № 4. С. 229–236.</mixed-citation><mixed-citation xml:lang="en">Maystrenko N. A. i dr. Cholangiocellular cancer (features of diagnosis and treatment) // Practical Oncology. 2008;(4):229–236. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wiedmann M. et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma : a phase II pilot study // Cancer. 2003. Vol. 97, № 11. P. 2783–2790.</mixed-citation><mixed-citation xml:lang="en">Wiedmann M. et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study // Cancer. 2003;97(11):2783–2790.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Witzigmann H. et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma : palliative photodynamic therapy plus stenting is comparable to r1/r2 resection // Ann. Surg. 2006. Vol. 244, № 2. P. 230–239.</mixed-citation><mixed-citation xml:lang="en">Witzigmann H. et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection /// Ann Surg. 2006;244(2):230–239.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Goenka M. K., Goenka U. Palliation : Hilar cholangiocarcinoma // World J. Hepatol. 2014. Vol. 39, № 6. P. 559–569.</mixed-citation><mixed-citation xml:lang="en">Goenka M. K., Goenka U. Palliation: Hilar cholangiocarcinoma // World J. Hepatol. 2014;39(6):559–569.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Farley D. R., Weaver A. L., Nagorney D. M. «Natural history» of unresected cholangiocarcinoma : patient outcome after noncurative intervention // Mayo Clin Proc. 1995. Vol. 70, № 5. P. 425–429.</mixed-citation><mixed-citation xml:lang="en">Farley D. R., Weaver A. L., Nagorney D. M. Natural history of unresected cholangiocarcinoma: patient outcome after noncurative intervention // Mayo Clin Proc. 1995;70(5):425–429.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jarnagin W. R. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma // Ann Surg. 2001. Vol. 234, № 4. P. 507–517.</mixed-citation><mixed-citation xml:lang="en">Jarnagin W. R. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma // Ann Surg. 2001;234(4):507–517.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Лапцевич Т. П. и др. Фотодинамическая терапия злокачественных опухолей : основы, история развития, перспективы (обзор) // Онколог. журн. 2008. № 1. С. 117–138.</mixed-citation><mixed-citation xml:lang="en">Laptsevich T. P. et al. Photodynamic therapy of malignant tumors: fundamentals, history of development, prospects (review) // Journal of Oncology. 2008;(1):117–138.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pahernik S. A. et al. Distribution and pharmacokinetics of Photofrin in human bile duct cancer // J. Photochem. Photobiol. 1998. Vol. 47, № 1. P. 58–62.</mixed-citation><mixed-citation xml:lang="en">Pahernik S. A. et al. Distribution and pharmacokinetics of Photofrin in human bile duct cancer // J Photochem Photobiol. 1998;47(1): 58–62.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Чан Тхи Хай Иен и др. Фотосенсибилизаторы хлоринового ряда в ФДТ опухолей // Рос. биотерапевт. журн. 2009. Т. 8, № 4. С. 99–104.</mixed-citation><mixed-citation xml:lang="en">Chan Thi Hai Yen et al. Chlorine-type photosensitizers in tumor PDT // Russian Biotherapeutic Journal. 2009;8(4):99–104.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gerhardt T. et al. Combination of bilateral metal stenting and transstent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma // J. Gastroenterol. 2010. Vol. 48, № 1. P. 28–32.</mixed-citation><mixed-citation xml:lang="en">Gerhardt T. et al. Combination of bilateral metal stenting and transstent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma // J Gastroenterol. 2010;48(1):28–32.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McCaughan J. S. et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report // Arch. Surg. 1991. Vol. 126, № 1. P. 111–113.</mixed-citation><mixed-citation xml:lang="en">McCaughan J. S. et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report // Arch Surg. 1991;126(1):111–113.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ortner M. E. et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma : a randomized prospective study // Gastroenterology. 2003. Vol. 125, № 5. P. 1355–1363.</mixed-citation><mixed-citation xml:lang="en">Ortner M. E. et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study // Gastroenterology. 2003;125(5):1355–1363.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zoepf T. et al. Palliation of nonresectable bile duct cancer : improved survival after photodynamic therapy // Am. J. Gastroenterol. 2005. Vol. 100, № 11. P. 2426–2430.</mixed-citation><mixed-citation xml:lang="en">Zoepf T. et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy // Am J Gastroenterol. 2005; 100(11):2426–2430.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira S. P. et al. PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stentingversus stenting alone in patients with locally advanced or metastatic biliary tract cancer // ESMO Open. 2018. Vol. 3, № 5.</mixed-citation><mixed-citation xml:lang="en">Pereira S. et al. P. PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stentingversus stenting alone in patients with locally advanced or metastatic biliary tract cancer // ESMO Open. 2018;3(5).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Moole H. et al. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma : A systematic review and metaanalysis // World J. Gastroenterol. 2017. Vol. 32, № 6. P. 1278–1288.</mixed-citation><mixed-citation xml:lang="en">Moole H. et al. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and metaanalysis // World J Gastroenterol. 2017;32(6):1278–1288.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Höblinger A. et al. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma// Eur. J. Med Res. 2011. Vol. 16, № 9. P. 391–395.</mixed-citation><mixed-citation xml:lang="en">Höblinger A. et al. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma // Eur J Med Res. 2011;16(9):391–395.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cheon Y. K. et al. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma // HPB (Oxford). 2012. Vol. 14, № 3. P. 185–193.</mixed-citation><mixed-citation xml:lang="en">Cheon Y. K. et al. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma // HPB (Oxford). 2012;14(3):185–193.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Prasad G. A. et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma // Clin. Gastroenterol. Hepatol. 2007. Vol. 5, № 6. P. 743–748.</mixed-citation><mixed-citation xml:lang="en">Prasad G. A. et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma // Clin Gastroenterol Hepatol. 2007;5(6):743–748.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Talreja J. P. et al. Photodynamic therapy for unresectable cholangiocarcinoma : contribution of single operator cholangioscopy for targeted treatment // Photochem Photobiol Sci. 2011. Vol. 10, № 7. P. 1233–1238.</mixed-citation><mixed-citation xml:lang="en">Talreja J. P. et al. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment // Photochem Photobiol Sci. 2011;10(7):1233–1238.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Wagner A. et al. Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma : A multicenter prospective phase II study // Hepatology. 2015. Vol. 62, № 5. P. 1456–1465.</mixed-citation><mixed-citation xml:lang="en">Wagner A. et al. Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study// Hepatology. 2015;62(5):1456–1465.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hong M. J. et al. Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma // Gut. Liver. 2014. Vol. 8, № 3. P. 318–323.</mixed-citation><mixed-citation xml:lang="en">Hong M. J. et al. Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma // Gut Liver. 2014;8(3):318–323.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wentrup R. et al. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma // Gut. Liver. 2016. Vol. 10, № 3. P. 470–475.</mixed-citation><mixed-citation xml:lang="en">Wentrup R. et al. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma // Gut Liver. 2016;10(3):470–475.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hauge T. et al. Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma – PCS Nordic study // Photodiagnosis Photodyn Ther. 2016. Vol. 13. P. 330–333.</mixed-citation><mixed-citation xml:lang="en">Hauge T. et al. Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma – PCS Nordic study // Photodiagnosis Photodyn Ther. 2016;13:330–333.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Гранов Д. А. и др. Комбинация методов регионарной терапии в лечении неоперабельной опухоли Клатскина // Высокотехнолог. мед. 2020. Т. 7, № 4. С. 8–16.</mixed-citation><mixed-citation xml:lang="en">Granov D. A. i dr. Combination of methods of regional therapy in the treatment of inoperable Klatskin tumor // High-tech medicine. 2020;7(4):8–16. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Nanashima A. et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery : a preliminary study // J. Gastroenterol. 2004. Vol. 39, № 11. P. 1095–1101.</mixed-citation><mixed-citation xml:lang="en">Nanashima A. et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study // J Gastroenterol. 2004; 39(11):1095–1101.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Cosgrove N. D. et al. Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation // Am. J. Transplant. 2014. Vol. 14, № 2. P. 466–71.</mixed-citation><mixed-citation xml:lang="en">Cosgrove N. D. et al. Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation // Am J Transplant. 2014;14( 2):466–71.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt A. et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma // United European Gastroenterol. J. 2016. Vol. 4, № 4. P. 570–579.</mixed-citation><mixed-citation xml:lang="en">Schmidt A. et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma // United European Gastroenterol J. 2016.;4(4):570–579.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Strand D. S. et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma // Gastrointest Endosc. 2014. Vol. 80, № 5. P. 794–804.</mixed-citation><mixed-citation xml:lang="en">Strand D. S. et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma // Gastrointest Endosc. 2014;80(5):794–804.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarez-Sánchez M. V., Napoléon B. Review of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safety // World J. Gastroenterol. 2016. Vol. 22, № 37. P. 8257–8270.</mixed-citation><mixed-citation xml:lang="en">Alvarez-Sánchez M. V., Napoléon B. Review of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safety // World J Gastroenterol. 2016;22(37) :8257–8270.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Steel A. W. et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction // Gastrointest Endosc. 2011. Vol. 73. P. 149–153.</mixed-citation><mixed-citation xml:lang="en">Steel A. W. et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction // Gastrointest Endosc. 2011;73:149–153.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J. et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial // Endoscopy. 2018. Vol. 50. P. 751–760.</mixed-citation><mixed-citation xml:lang="en">Yang J. et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial // Endoscopy. 2018;50:751–760.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng X. et al. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction : A systematic review and meta-analysis // Journal of Digestive Diseases. 2016. Vol. 17. P. 716– 724.</mixed-citation><mixed-citation xml:lang="en">Zheng X. et al. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta-analysis // Journal of Digestive Diseases. 2016;17:716–724.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Sofi A. A. et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures : a systematic review and meta-analysis // Gastrointest. Endosc. 2018. Vol. 87. P. 944–951.</mixed-citation><mixed-citation xml:lang="en">Sofi A. A. et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis // Gastrointest Endosc. 2018;87:944–951.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y. et al. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma // Oncotarget. 2016. Vol. 7, № 33. P. 53911–53920.</mixed-citation><mixed-citation xml:lang="en">Wang Y. et al. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma // Oncotarget. 2016;7(33):53911–53920.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Wu T. et al. Percutaneous Intraluminal Radiofrequency Ablation for Malignant Extrahepatic Biliary Obstruction: A Safe and Feasible Method // Dig Dis Sci. 2015. Vol. 60, № 7. P. 2158–2163.</mixed-citation><mixed-citation xml:lang="en">Wu T. et al. Percutaneous Intraluminal Radiofrequency Ablation for Malignant Extrahepatic Biliary Obstruction: A Safe and Feasible Method // Dig Dis Sci. 2015;60(7):2158–2163.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Pozsa´r J. et al. Intraductal radiofrequency ablation can restore patency of occluded biliary selfexpanding metal stents // Z. Gastroenterol. 2011. Vol. 49. Р. 70.</mixed-citation><mixed-citation xml:lang="en">Pozsa´r J. et al. Intraductal radiofrequency ablation can restore patency of occluded biliary selfexpanding metal stents // Z Gastroenterol. 2011;49:70.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kadayifci A. et al. Radiofrequency ablation for the management of occluded biliary metal stents // Endoscopy. 2016. Vol. 48. P. 1096.</mixed-citation><mixed-citation xml:lang="en">Kadayifci A. et al. Radiofrequency ablation for the management of occluded biliary metal stents // Endoscopy. 2016;48:1096.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Xia N. et al. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion : A preliminary result // World J. Gastroenterol. 2017. Vol. 23, № 10. P. 1851–1856.</mixed-citation><mixed-citation xml:lang="en">Xia N. et al. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result // World J Gastroenterol. 2017;23(10):1851–1856.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
